Huhtamaki India (HUHTAMAKI)

FairStock Score: 58/100 — STEADY

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Low leverage: Debt/Equity of just 0.11, providing financial safety.
• High promoter holding of 67.73%, aligning management with minority shareholders.
• Attractive valuation: P/E of 11.35 and P/B of 1.17, near the 52-week low.
• Piotroski F-Score of 7/9 suggests improving fundamental health.
• ROCE of 12.95% exceeds ROE of 9.90%, indicating reasonable capital deployment.

Concerns

• Sales growth is nearly flat at 0.55%, so the 157% profit growth may not be durable.
• ROE of 9.90% is modest for a quality compounder.
• Stock has fallen sharply from ₹320.78 to ₹184.63, reflecting market skepticism.
• Packaging is a competitive, low-differentiation industry with limited pricing power.
• Stated free cash flow figure of ₹95.15 lakh Cr appears inconsistent with the business scale and market cap.

AI Analysis

Diving into Huhtamaki India, I see a packaging business selling at a price my mentor Graham would examine with care but not enthusiasm. At ₹184.63, market cap ₹1,333 Cr, P/E 11.35 and P/B 1.17. Book value ₹157.82 gives a modest premium to assets. The balance sheet is clean: debt/equity 0.11, ROCE 12.95%, F-score 7/9. Promoter holding 67.73% is comforting, though not a moat. Profit growth of 157% grabs attention, but sales growth of 0.55% tells me this is not a franchise compounding revenue. It is an earnings rebound, perhaps from cost cuts, raw material tailwinds, or a low base. The latest quarter net profit of ₹30 Cr on sales of ₹623 Cr shows margin recovery; annualised, that roughly justifies the low P/E. But ROE of 9.90% is mediocre; a wonderful business would earn far more on equity. The 52-week range of ₹148.60 to ₹320.78, with the stock near the bottom, suggests Mr. Market has doubts. I must be honest: packaging is competitive, and Huhtamaki has not demonstrated pricing power. The reported free cash flow of ₹95.15 lakh Cr is so far above the market cap that I cannot rely on it without an explanation. As a value investor, I like the low debt and reasonable entry price, but I need evidence of durable demand and improving sales. This looks like a turnaround situation: profitable, conservatively financed, yet with stagnant revenue. I would wait for stronger operating results or a bigger discount to book before committing. Patience is the investor's greatest ally.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer